Boosting chemical by-product of dietary fiber fermentation in gut slims and trims
Propionate-friendly fibre intake may offer new weight management option, say researchers
2014-12-11
(Press-News.org) This approach may offer a new weight management option, suggest the researchers.
Animal studies have shown that the natural fermentation of dietary fibre by gut bacteria produces short chain fatty acids, one of which is propionate.
These fatty acids stimulate the release of the gut hormones PYY and GLP-1, which in turn suppress appetite. And propionate seems to be the most effective at stimulating PYY and GLP-1 release.
To find out if increasing levels of propionate in the bowel could reduce food intake and stave off weight gain in people, the researchers developed a propionate supplement primed to target propionate release in the bowel.
First, 20 volunteers were given either the propionate supplement or just inulin, a predominantly fructose-containing plant fibre, and allowed to eat as much as they liked from a buffet. When given the propionate supplement, participants ate 14% less, on average, and had higher levels of PYY and GLP-1 in their blood.
Next, 60 overweight adults between the ages of 40 and 65 received either a daily 10 g dose of the propionate supplement or 10 g of inulin alone over a period of 24 weeks. They were asked to follow their normal dietary and exercise routines throughout.
Body weight was assessed at the beginning and end of the study period, as was the distribution of fat around the body.
A fasting blood sample was also taken to check on risk factors for cardiovascular disease and diabetes, including blood fats, liver enzymes, and markers of inflammation.
Forty nine of the original 60 participants completed the trial.
Among the 25 people taking the propionate supplement, just one put on more than 3% of their baseline weight, compared with six of the 24 treated with inulin alone.
Furthermore, the propionate supplement altered the distribution of body fat, significantly trimming abdominal fat tissue compared with inulin alone, and lowering the total amount of fat in the liver.
Both the propionate supplement and inulin cut the risk factors for cardiovascular disease and diabetes, although only the propionate supplement significantly reduced 'bad' low density cholesterol and the enzyme aspartate transaminase, high levels of which are associated with tissue damage, particularly of the heart and liver.
The evidence suggests that adults gain around half to 1 kilo in weight every year throughout middle age by just consuming 50-100 extra calories a day. And the findings provide the first direct evidence that raising propionate levels in the bowel can cut energy intake and stave off longer term weight gain, say the researchers.
"The present results support a role specifically for colonic propionate in weight management and may provide a molecular explanation of recent data that have observed changes in the gut [range of bacteria] and associated [short chain fatty acid production] profiles in weight loss," they conclude.
INFORMATION:
ELSE PRESS RELEASES FROM THIS DATE:
2014-12-11
Dietary guidelines should emphasise the role played by added sugars, particularly fructose, in the fight to curb the prevalence of cardiovascular, they insist.
Cardiovascular disease is the number one cause of premature death in the developed world. And high blood pressure is its most important risk factor,accounting for almost 350,000 deaths in the US in 2009 and costing more than $50 billion US dollars every year.
Dietary approaches to lower high blood pressure have historically focused on cutting salt intake. But the potential benefits of this approach "are debatable," ...
2014-12-11
Those with the largest waists and hips combined are twice as likely to be affected as those with measurements in the normal range, the findings indicate.
Sudden cardiac death, or SCD for short, occurs without warning, and is caused by a sudden unexpected loss of heart function, which rapidly reduces blood flow around the body, including to the brain. It is distinct from a heart attack, and kills around 300,000 people in the USA every year.
Obesity has long been associated with various unfavourable changes in cardiovascular health, including SCD. But the researchers ...
2014-12-11
SAN ANTONIO, TX, USA and Neu-Isenburg/Frankfurt, Germany -- December 10, 2014 -- The German Breast Group (GBG) said nab-paclitaxel (ABRAXANE®) demonstrated significant benefit for patients with early high risk breast cancer when compared to conventional solvent-based paclitaxel. The findings are from the GeparSepto clinical trial sponsored by GBG and conducted together with the German AGO-B study group involving over 1200 patients, which is the largest randomized Phase III study ever completed with nab-paclitaxel and the first one completed in high risk early breast ...
2014-12-11
Scientists have developed an ingredient that can be added to foods to make them more filling.
In its first tests in humans, researchers at Imperial College London and the University of Glasgow found that the ingredient is effective at preventing weight gain in overweight volunteers.
The ingredient contains propionate, which stimulates the gut to release hormones that act on the brain to reduce hunger. Propionate is produced naturally when dietary fibre is fermented by microbes in the gut, but the new ingredient, called inulin-propionate ester (IPE), provides much larger ...
2014-12-11
PROVIDENCE, R.I. [Brown University] -- A study of more than 12 million acute care hospitalizations over a five-year span found that as quality improved on each of 17 measures so did racial and ethnic equity. Nine major disparities evident in 2005 had mostly or totally disappeared by the end of 2010.
The study, led by Dr. Amal Trivedi of Brown University and published in the New England Journal of Medicine, found that care for blacks and Hispanics became better and more equitable when comparing hospitals principally serving whites to hospitals principally serving minorities, ...
2014-12-11
Despite recent significant gains in health care access throughout the nation, people of color continue to grapple with a disproportionate burden of chronic disease. Two studies in the current issue of the New England Journal of Medicine (NEJM) indicate that differences in how care is delivered to patients in various racial or ethnic groups have narrowed nationally, but health outcomes remain worse for blacks than for whites.
In his editorial "How to Achieve Health Equity," also published in the just released NEJM, Marshall Chin, MD, MPH, the Richard Parrillo Family Professor ...
2014-12-11
WASHINGTON -- A five-minute functional MRI (fMRI) test can pick up neuronal dysfunction in HIV-positive individuals who don't yet exhibit cognitive decline, say neuroscientists and clinicians at Georgetown University Medical Center.
Their study in Neuroimaging: Clinical provides proof-of-concept that imaging can help track neural functioning in this population, known to be affected by the virus and potentially by the treatments meant to keep HIV at bay.
The issue of neural dysfunction in the HIV-positive population is significant, says Georgetown neuroscientist Xiong ...
2014-12-11
ANN ARBOR, Mich. -- Despite years of effort to help American seniors with high blood pressure, heart disease, or diabetes get their blood pressure, cholesterol and blood sugar under control, new research shows wide gaps between older people of different ethnic backgrounds in all three of these key health measures.
Black seniors in Medicare Advantage health plans are still much less likely than their white peers to have each of the three measures in check, according to a new study published in the December 11 issue of the New England Journal of Medicine.
If not well ...
2014-12-11
Treatment of acute traumatic brain injury with the hormone progesterone provides no significant benefit to patients when compared with placebo, a NIH-funded phase III clinical trial has concluded.
The results are scheduled for publication Dec. 10 in the New England Journal of Medicine.
The study, named ProTECT III, involved 49 trauma centers across the United States between July 2009 and November 2013. The study was originally planned to include 1,140 patients, but was stopped after 882 patients because safety monitors determined that additional enrollment would be ...
2014-12-11
A study concluded that after five days of treatment with a novel formulation of progesterone acutely administered to patients with severe traumatic brain injury (TBI), showed no clinical benefits.
The paper entitled, "A Clinical Trial of Progesterone for Severe Traumatic Brain Injury," will be published online in The New England Journal of Medicine, December 10, 2014.
This trial, referred to as SyNAPSe, reports on a large prospective randomized clinical trial that investigated the effects of progesterone administered to severe TBI patients," said Raj K. Narayan, ...
LAST 30 PRESS RELEASES:
[Press-News.org] Boosting chemical by-product of dietary fiber fermentation in gut slims and trims
Propionate-friendly fibre intake may offer new weight management option, say researchers
